.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Analyze global market entry opportunities
  • Uncover prior art in abandoned patent applications and expired patents

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

NATEGLINIDE Drug Profile

« Back to Dashboard

Which patents cover Nateglinide, and what substitute generic drugs are available?

Nateglinide is a drug marketed by Zydus Pharms Usa Inc, Alvogen Malta, Dr Reddys Labs Ltd, Watson Labs, Par Pharm, and Teva Pharms. and is included in six NDAs.

The generic ingredient in NATEGLINIDE is nateglinide. There are nine drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the nateglinide profile page.

Summary for Tradename: NATEGLINIDE

Patents:0
Applicants:6
NDAs:6
Suppliers / Packagers: see list10
Bulk Api Vendors: see list54
Clinical Trials: see list7
Patent Applications: see list4,760
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:NATEGLINIDE at DailyMed

Pharmacology for Tradename: NATEGLINIDE

Drug ClassGlinide
Mechanism of ActionPotassium Channel Antagonists
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Zydus Pharms Usa Inc
NATEGLINIDE
nateglinide
TABLET;ORAL205248-001Jul 6, 2016RXNoNo► Subscribe► Subscribe
Watson Labs
NATEGLINIDE
nateglinide
TABLET;ORAL077462-001Mar 30, 2011RXNoNo► Subscribe► Subscribe
Alvogen Malta
NATEGLINIDE
nateglinide
TABLET;ORAL205055-002Dec 11, 2015RXNoNo► Subscribe► Subscribe
Teva Pharms
NATEGLINIDE
nateglinide
TABLET;ORAL077467-002Sep 9, 2009DISCNNoNo► Subscribe► Subscribe
Watson Labs
NATEGLINIDE
nateglinide
TABLET;ORAL077462-002Mar 30, 2011RXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc